Actavis’ Pulmicort Respules Generics Race Out The Door Before “Short Injunction”
Executive Summary
The company is barred from further distributing its budesonide inhalation suspension until April 12; the generic launched April 1 following a patent victory over AstraZeneca, but a New Jersey federal judge said a “limited temporary injunction” was warranted to give the innovator time to seek appellate relief.